Liver transplant procedure acts as a challenge for transfusion services in terms of specialized blood components, serologic problems, and immunologic effects of transfusion. Red cell alloimmunization in patients awaiting a liver transplant complicate the process by undue delay or unavailability of compatible red blood cell units. Compatible blood units can be provided by well-equipped immunohematology laboratory, which has expertise in resolving these serological problems. This report illustrates resolution of a case with multiple alloantibodies using standard techniques, particularly rare antisera. Our case re-emphasizes the need for universal antibody screening in all patients as part of pretransfusion testing, which helps to identify atypical antibodies and plan for appropriate transfusion support well in time. We recommend that the centers, especially the ones that perform complex procedures like solid organ transplants and hematological transplants should have the necessary immunohematological reagents including rare antisera to resolve complex cases of multiple antibodies as illustrated in this case.
Introduction Introduction
Liver transplantation is a treatment of choice for patients with acute or chronic end-stage liver disease (ESLD). Liver transplants earlier required a large amount of blood transfusions, but the transfusion requirement in liver transplant has declined during the last few years. [1] Liver transplant procedures act as a challenge for transfusion services in terms of specialized blood components, serologic problems, and immunologic effects of transfusion. Blood transfusion itself is recognized poor prognostic factor in liver transplant recipients because of its adverse effects such as transfusion reactions, viral and bacterial contamination of blood products, and transfusion related immune modulation. [2] Red cell alloimmunization adds to this as the presence of red cell alloantibodies in patients awaiting a liver transplant may cause delay or unavailability of compatible red blood cell (RBC) units creating pressure over caregivers. Compatible blood units can be provided by well-equipped immunohematology laboratory with expertise in resolving serological problems. Such competence is essential for a successful liver transplantation program. In this report, we present our approach in a patient awaiting a liver transplant with clinically signifi cant multiple red cell alloantibodies.
We present a case of 49-year-old male diagnosed with ESLD and scheduled for liver transplant. Immunohematology laboratory received a sample for alloantibody identifi cation and providing compatible red cell units required for liver transplant. All procedures were performed as per the departmental standard operating procedure and manufacturer's instructions were followed.
Blood Grouping Blood Grouping
On blood grouping the patient was A Rh (D) positive.
Direct Antiglobulin Test and Direct Antiglobulin Test and
Autocontrol Autocontrol
The patient sample was direct antiglobulin test (DAT) positive (4+; polyspecifi c) and autocontrol was also positive (2+). In monospecifi c DAT cassette, the anti-IgG was 3+ and anti-C3d was negative. Cold acid elution (Elutions-System, BAG Amtsgerichtsstra Health Care, Germany) was performed on the patient's red cells. The eluate was tested for antibody specifi city, but remained inconclusive.
Autoadsorption was performed using two sets of papain-treated (Liquipap, Tulip Diagnostics, Goa, India) autologous red cells. The antibody screen and identifi cation was performed using adsorbed plasma. Table 4 ]. These red cell alloantibodies were also re-confi rmed on a fresh sample of the patient. Considering the antigen negative frequency in our donor population for c, E and Fy b (50.52%, 81.1% and 43.85%) 12 O Rh (D) positive units were typed for fi nding four more compatible units. [3] Thus, total of 11 (c−, E− and Fy b −) RBC cross-match compatible units were issued and transfused to the patient during liver transplant. Intraoperatively, he received fi ve red cells, six fresh frozen plasmas, one cryoprecipitate, and two single donor platelets without any adverse effects like hemolysis. In the postoperative period, one red cell unit was transfused which remained uneventful. Titers of anti-c, anti-E and anti-Fy b alloantibody were 32, 2, and 2, respectively. The patient had a previous history of transfusion of four units of A Rh (D) positive red cell units in some other hospital 3 months ago. This previous transfusion could be the source of alloimmunization.
The patient was followed-up after the liver transplant during the hospital stay and telephonically after his discharge from the hospital. The patient continues to be alright with normal liver function tests and normal hemoglobin (10.2 g%).
Discussion Discussion
Considering the alloimmunization due to transfusion, overall 1% of patients in the general population and 18.6% in multi-transfused patients develop RBC alloantibodies. [4] The incidence of red cell alloantibodies at our center in general patient population is 1% [5] while in multi-transfused patient's in India incidence is 7.7% as reported by Patel et al. [6] In the first UK published survey of red cell alloimmunization in adults undergoing liver transplant, 8% of adults were reported to have red cell antibodies, out of which 6.8% were clinically signifi cant. This was in contrast with their general patient population in which the prevalence of red cell alloimmunization was 2-3%. [7] Luzo et al. have reported 23% incidence of red cell alloantibodies among liver transplantation patients in their center. [8] In our patient awaiting a liver transplant, three red cell alloantibodies were identifi ed of which two were againstRh (anti-c, anti-E) and one against Fy (anti-Fy b ) blood group system. The most common red cell alloantibody in liver transplants recipients reported by Mushkbar et al. from UK was anti Rh and anti Kell (K). [7] Ramsey et al. also reported anti K, Rh and Jk a as the most common red cell antibodies in 496 adults and 286 children undergoing 1000 consecutive transplants in Pittsburgh. [9] For fi nding out compatible units for this patient with multiple antibodies large number of units are to be typed. In our case, 57 units were typed to get 11 antigen negative compatible blood units, which shows that 19% of units were antigen-negative and this corroborates with expected antigen-negative units. Other approaches could also be of benefi t in providing transfusion with diffi cult RBC antibodies like intra-operative blood salvage [10] and use of rare donor registries [11] for respective antigen negative blood units, while if blood requirement is quite high, ABOcompatible units that have not been typed for all antigens may be transfused initially and once the patient stabilizes, antigennegative RBCs are given again at the end of the procedure, to minimize the risk of serious delayed hemolytic transfusion reactions. [12] This strategy takes advantage of hemodilution and antibody washout in initial stages of transfusion. However, the timing of switching back to antigen negative compatible blood can't be clearly defi ned, potentially putting the patient at risk for delayed hemolytic transfusion reaction and increasing postoperative morbidity. Thompson et al. [13] suggested to avoid at least complement fi xing antibodies when suffi cient antigennegative blood cannot be obtained as they can potentially cause severe intravascular hemolysis. Another approach would be to do plasma exchange to remove or reduce the titers of clinically signifi cant alloantibodies.
This case highlights the importance of antibody screening and identifi cation as a part of pretransfusion testing in identifying irregular red cell antibodies and proper planning for transfusion support as failure to recognize all the irregular antibodies in a patient may lead to hemolytic transfusion reaction. In our case, anti Rh (anti-c and anti-E) was identifi ed in time while anti-Fy b was initially missed as cell 11 in our identifi cation panel was negative which was later identifi ed, while cross-matching antigen (c and E) negative units. This might be due to loss of blood group antigens (labile antigens) from reagent cells, as they were towards the end of their recommended storage period. Fy a and Fy b tend to elute from red cells stored in low pH low-ionic strength medium, and even after a prolonged storage, or mixing, in saline at pH-7. [14] Recent guidelines by British blood transfusion society for pretransfusion compatibility procedures state that reagent cells should be preserved in the temperature-controlled environment in diluents shown to minimize loss of blood group antigens during storage and stability of screening cells should be validated locally for routine use in laboratory. BCSH also recommends the use of controls, containing weak examples of antibodies (weak anti-D <0.1 IU/mL) and weak anti-Fy a to assure the sensitivity of the test procedure and integrity of antigen expression of reagent red cells during storage. [15] This case also highlights the importance of extended phenotyping as anti-Duffy antibody was identifi ed by extended phenotyping of all cross-match compatible and incompatible units. Extended phenotyping plays a major role, especially when multiple antibodies are suspected, but reagent control or AB serum control with the same technique should be incorporated. [15] Transfusion service provides vital support of the liver transplant program and preparation of transfusion support for organ transplant starts early in the preoperative period with antibody screening and identifi cation to identify irregular antibodies and appropriate transfusion support in time. Our case re-emphasizes the need for antibody screening as part of pretransfusion testing. We also recommend that all centers, especially those which perform solid organ transplants and hematological transplants should develop necessary competence to resolve complex cases of multiple antibodies. Since developing such competences could be challenging, we can identify an existing laboratory with requisite competence as a reference laboratory to solve such complex cases.
